Navegar por autor "Turnes Vázquez, Juan"

Absceso hepatico como complicaciondiferida a cuerpo extrano gastrointestinal.

2011- Vazquez Rodriguez, Sergio; Turnes Vázquez, Juan; González Carrera, Victor; Álvarez Sánchez, María Victoria

Addition of simvastatin to standard treatment improves survival after variceal bleeding in patients with cirrhosis. A double-blind randomized trial (nct01095185)

2014- Turnes Vázquez, Juan

Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)

2013- Turnes Vázquez, Juan

Application of the Barcelona clinic liver cancer therapeutic strategy and impact on survival

2015- Turnes Vázquez, Juan

Circuito asistencial rápido para paciente con sospecha de cáncer colorrectal

2017-01-01- Turnes Vázquez, Juan; Carbajo Vicente, Ana Marta; Sánchez Rodríguez, María Belén; Sánchez Santos, Raquel

Colorectal neoplasm fast track diagnosis pathways

2019-10- Pérez Cachafeiro, Santiago; Said Criado, Ismael; Morán Hermida, Luis Manuel; Salgado Barreira, Angel; Ocampo Fontagordo, Marta; [et al.]

Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies

2013- Turnes Vázquez, Juan

cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients

2013- Turnes Vázquez, Juan

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

2015- Fernandez Castroagudin, Javier; Turnes Vázquez, Juan; Salgado Fernández, Mercedes; Martín-Granizo Barrenechea, Ignacio

Efectividad del plan de contingencia de la Unidad de Enfermedad Inflamatoria Intestinal ante la infección de Covid-19.

2020-06-16- Carpio López, Daniel; MARTINEZ PILLADO, MODESTO; Salgado Barreira, Angel; Daponte Angueira, Sandra; Díez Lage, Raquel; [et al.]

Esophago-Gastric Pathology in Morbid Obese: Preoperative Diagnosis and Influence in Technique Selection

2011- Ulla Rocha, Jóse Luis; Piñón Cimadevila, Miguel Angel; Sánchez Santos, Raquel; Estévez Fernández, Sergio Manuel; Turnes Vázquez, Juan; [et al.]

Esophagogastric disease in the morbidly obese: preoperative diagnosis and influence in the selection of the surgical technique

2015- Sánchez Santos, Raquel; Estévez Fernández, Sergio Manuel; Turnes Vázquez, Juan; González Fernández, Sonia; Mariño Padín, Esther [et al.]

Estratexia para a eliminación da hepatite C como problema de saúde pública en Galicia

2022- Turnes Vázquez, Juan; Cruz Ferro, Elena; Mirás Carballal, Susana; Zubizarreta Alberdi, Raquel; Cea Pereira, Lorena; [et al.]

Final analysis of aetiology/comorbidities in European patients from the gideon (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib) study

2014- Turnes Vázquez, Juan

Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems

2014- Turnes Vázquez, Juan

Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

2020- Mangia, A.; Milligan, S.; Khalili, M.; Fagiuoli, S.; Shafran, S. D.; [et al.]

IL28B-BASED MODEL FOR PREDICTION OF WEEK 4 VIRAL RESPONSE IN PEGINTERFERON-alfa2a+RIBAVIRIN TREATED HEPATITIS C GENOTYPE 1&4. FINAL REPORT WEEK 4 OPTIM STUDY

2013- Turnes Vázquez, Juan

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study

2015- Turnes Vázquez, Juan

Los pacientes con antecedentes de crisis epilépticas infectados por el virus de la hepatitis C pueden y deben ser tratados con terapia estándar

2013- Turnes Vázquez, Juan

Meta-analysis: pegylated interferon-2a achieves higher early virological responses than-2b in chronic hepatitis C

2013- Turnes Vázquez, Juan

Repositorio digital RUNA

Navegar por autor "Turnes Vázquez, Juan"

Absceso hepatico como complicaciondiferida a cuerpo extrano gastrointestinal. ﻿

Addition of simvastatin to standard treatment improves survival after variceal bleeding in patients with cirrhosis. A double-blind randomized trial (nct01095185) ﻿

Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts) ﻿

Application of the Barcelona clinic liver cancer therapeutic strategy and impact on survival ﻿

Circuito asistencial rápido para paciente con sospecha de cáncer colorrectal ﻿

Colorectal neoplasm fast track diagnosis pathways ﻿

Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies ﻿

cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients ﻿

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España ﻿

Efectividad del plan de contingencia de la Unidad de Enfermedad Inflamatoria Intestinal ante la infección de Covid-19. ﻿

Esophago-Gastric Pathology in Morbid Obese: Preoperative Diagnosis and Influence in Technique Selection ﻿

Esophagogastric disease in the morbidly obese: preoperative diagnosis and influence in the selection of the surgical technique ﻿

Estratexia para a eliminación da hepatite C como problema de saúde pública en Galicia ﻿

Final analysis of aetiology/comorbidities in European patients from the gideon (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib) study ﻿

Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems ﻿

Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts ﻿

IL28B-BASED MODEL FOR PREDICTION OF WEEK 4 VIRAL RESPONSE IN PEGINTERFERON-alfa2a+RIBAVIRIN TREATED HEPATITIS C GENOTYPE 1&4. FINAL REPORT WEEK 4 OPTIM STUDY ﻿

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study ﻿

Los pacientes con antecedentes de crisis epilépticas infectados por el virus de la hepatitis C pueden y deben ser tratados con terapia estándar ﻿

Meta-analysis: pegylated interferon-2a achieves higher early virological responses than-2b in chronic hepatitis C ﻿

Absceso hepatico como complicaciondiferida a cuerpo extrano gastrointestinal.

Addition of simvastatin to standard treatment improves survival after variceal bleeding in patients with cirrhosis. A double-blind randomized trial (nct01095185)

Analysis of sorafenib starting dose and outcomes from the European subset of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib SOR ) in > 1000 patients (pts)

Application of the Barcelona clinic liver cancer therapeutic strategy and impact on survival

Circuito asistencial rápido para paciente con sospecha de cáncer colorrectal

Colorectal neoplasm fast track diagnosis pathways

Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies

cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients

Decisiones terapéuticas en el tratamiento del carcinoma hepatocelular y patrones de uso de sorafenib. Resultados del estudio internacional observacional GIDEON en España

Efectividad del plan de contingencia de la Unidad de Enfermedad Inflamatoria Intestinal ante la infección de Covid-19.

Esophago-Gastric Pathology in Morbid Obese: Preoperative Diagnosis and Influence in Technique Selection

Esophagogastric disease in the morbidly obese: preoperative diagnosis and influence in the selection of the surgical technique

Estratexia para a eliminación da hepatite C como problema de saúde pública en Galicia

Final analysis of aetiology/comorbidities in European patients from the gideon (global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib) study

Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems

Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts

IL28B-BASED MODEL FOR PREDICTION OF WEEK 4 VIRAL RESPONSE IN PEGINTERFERON-alfa2a+RIBAVIRIN TREATED HEPATITIS C GENOTYPE 1&4. FINAL REPORT WEEK 4 OPTIM STUDY

Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study

Los pacientes con antecedentes de crisis epilépticas infectados por el virus de la hepatitis C pueden y deben ser tratados con terapia estándar

Meta-analysis: pegylated interferon-2a achieves higher early virological responses than-2b in chronic hepatitis C